Please use this identifier to cite or link to this item:
Title: Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Aged, 80 and over,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Deoxycytidine/administration & dosage/adverse effects/analogs & derivatives,Doxorubicin/administration & dosage/adverse effects,Drug Administration Schedule,Drug Resistance, Multiple,Drug Resistance, Neoplasm,Female,Humans,Middle Aged,Organoplatinum Compounds/therapeutic use,Ovarian Neoplasms/*drug therapy,Taxoids/therapeutic use
ISSN: 0250-7005
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Pavlidis-2005-gemcitabine plus pegylated.pdf67.43 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons